Everolimus

Sold as Xience v, Afinitor, Promus, Everzor, Everolimus adco, Afinviat, Everolimus DRL, Verobit, Everolimus equity, Certican

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 8
Registrations: 25
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Baroque Pharmaceuticals (Pty) Ltd	Xience v	Not stated	420699	S4	None
Novartis South Africa (Pty) Ltd	Afinitor, Certican	0,25, 0,75, 5 mg, 10 mg	431010, 431133, A380686, A380687	S4	PI PIL
Bliss Pharmaceuticals (Pty) Ltd	Promus	Not stated	440199	S4	None
Adcock ingram limited	Everzor, Everolimus adco	2.5 mg/5 mg/10 mg, 2,5, 5, 10	530489, 530490, 530491, 530492.489, 530493.49, 530494.491	S4	PI PIL
Viatris South Africa (Pty) Ltd	Afinviat	2,5 mg, 5 mg, 10 mg	560897, 560898, 560899	S4	None
Dr Reddyæs Laboratories (Pty) Ltd	Everolimus DRL	2,5, 5, 10	561173, 561174, 561175	S4	None
Ascend Laboratories (Pty) Ltd	Verobit	0,25 mg, 0,50 mg, 0,75 mg, 1 mg	570703, 570704, 570705, 570706	S4	None
Equity Pharmaceutical (Pty) Ltd	Everolimus equity	2,5, 5, 10	570732, 570733, 570734	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Xience v EACH STENT CONTAINS EVEROLIMUS 100,0 ug/cm	Not listed	42069942/34/0699	Registered	S4	None
Afinitor 5 MG EACH TABLET CONTAINS EVEROLIMUS 5,0 mg	5 mg	43101043/34/1010	Registered	S4	None
Afinitor 10 MG EACH TABLET CONTAINS EVEROLIMUS 10,0 mg	10 mg	43113343/34/1133	Registered	S4	None
Promus EACH STENT CONTAINS EVEROLIMUS 37,0 ug	Not listed	44019944/32.2/0199	Registered	S4	None
Everzor 2,5 EACH TABLET CONTAINS EVEROLIMUS 2,5 mg	2.5 mg/5 mg/10 mgTablets	53048953/34/0489Approved 29 April 2022	Registered	S4	PI PIL
Everzor 5 EACH TABLET CONTAINS EVEROLIMUS 5 mg	2.5 mg/5 mg/10 mgTablets	53049053/34/0490Approved 29 April 2022	Registered	S4	PI PIL
Everzor 10 EACH TABLET CONTAINS EVEROLIMUS 10 mg	2.5 mg/5 mg/10 mgTablets	53049153/34/0491Approved 29 April 2022	Registered	S4	PI PIL
Everolimus 2,5 adco EACH TABLET CONTAINS EVEROLIMUS 2,5 mg	2,5	530492.48953/34/0492.489	Registered	S4	None
Everolimus 5 adco EACH TABLET CONTAINS EVEROLIMUS 5 mg	5	530493.4953/34/0493.490	Registered	S4	None
Everolimus 10 adco EACH TABLET CONTAINS EVEROLIMUS 10 mg	10	530494.49153/34/0494.491	Registered	S4	None
Afinviat 2,5 MG EACH TABLET CONTAINS: EVEROLIMUS 2,5 mg	2,5 mg	56089756/32.16/0897	Registered	S4	None
Afinviat 5 MG EACH TABLET CONTAINS: EVEROLIMUS 5,0 mg	5 mg	56089856/32.16/0898	Registered	S4	None
Afinviat 10 MG EACH TABLET CONTAINS: EVEROLIMUS 10,0 mg	10 mg	56089956/32.16/0899	Registered	S4	None
Everolimus 2,5 DRL EACH TABLET CONTAINS: EVEROLIMUS 2,5 mg	2,5	56117356/32.16/1173	Registered	S4	None
Everolimus 5 DRL EACH TABLET CONTAINS: EVEROLIMUS 5,0 mg	5	56117456/32.16/1174	Registered	S4	None
Everolimus 10 DRL EACH TABLET CONTAINS: EVEROLIMUS 10,0 mg	10	56117556/32.16/1175	Registered	S4	None
Verobit 0,25 MG EACH TABLET CONTAINS: EVEROLIMUS 0,25 mg	0,25 mg	57070357/32.16/0703	Registered	S4	None
Verobit 0,50 MG EACH TABLET CONTAINS: EVEROLIMUS 0,5 mg	0,50 mg	57070457/32.16/0704	Registered	S4	None
Verobit 0,75 MG EACH TABLET CONTAINS: EVEROLIMUS 0,75 mg	0,75 mg	57070557/32.16/0705	Registered	S4	None
Verobit 1 MG EACH TABLET CONTAINS: EVEROLIMUS 1,0 mg	1 mg	57070657/32.16/0706	Registered	S4	None
Everolimus 2,5 equity EACH TABLET CONTAINS: EVEROLIMUS 2,5 mg	2,5	57073257/32.16/0732	Registered	S4	None
Everolimus 5 equity EACH TABLET CONTAINS: EVEROLIMUS 5,0 mg	5	57073357/32.16/0733	Registered	S4	None
Everolimus 10 equity EACH TABLET CONTAINS: EVEROLIMUS 10,0 mg	10	57073457/32.16/0734	Registered	S4	None
Certican 0,25 EACH TABLET CONTAINS EVEROLIMUS 0,25 mg	0,25Tablet.	A380686A38/34/0686Approved 27 February 2023	Registered	S4	PI PIL
Certican 0,75 EACH TABLET CONTAINS EVEROLIMUS 0,75 mg	0,75Tablet.	A380687A38/34/0687Approved 27 February 2023	Registered	S4	PI PIL

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Everolimus

S4: Everolimus
Consolidated Schedules 06 July 2026, line 6296

Pharmacological class: Complementary Medicines: Health Supplements (class 34)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Everzor 2,5, Adcock ingram limited is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsEverzor 2,5, Adcock ingram limited Patient information leaflet (PIL)For patients and carersEverzor 2,5, Adcock ingram limited

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background